
    
      To establish cut off levels of platelet inhibition using ADP-induced P2Y12-receptor mediated
      platelet aggregation using Accumetrics VerifyNow P2Y12 assay (PRU) and Vasodilator-stimulated
      phosphoprotein (VASP, PRI %)for patients with experienced stent occlusion with acute clinical
      onset and/or myocardial infarction within 6 months after coronary stenting for coronary
      artery disease.
    
  